Skip to main content

Table 5 Regression analysis of risk factors associated with infection-related death among 127 patients infected by CRE between March 2011 and December 2012

From: A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome

Variable

Total

Survivors

Deaths

OR (95 % CI)

P

First model

 60 y or over

57 (44.9 %)

32 (38.5 %)

25 (56.8 %)

2.72

(0.93–7.95)

0.06

 Shock

63 (49.6 %)

25 (30.1 %)

38 (86.4 %)

10.26

(2.95–35.68)

0.0002

 Dialysis

45 (35.4 %)

18 (21.7 %)

27 (61.4 %)

2.94

(1.00–8.62)

0.04

 Sensitive ATM less than 12 h

31 (24.4 %)

14 (16.9 %)

17 (38.6 %)

1.80

(0.63–5.14)

0.27

 UTI

51 (40.2 %)

39 (47.0 %)

12 (27.3 %)

0.71

(0.14–3.62)

0.68

 Pneumonia

52 (41.0 %)

25 (30.1 %)

27 (61.4 %)

1.58

(0.40–6.18)

0.50

 Monotherapy

29 (22.8 %)

23 (27.7 %)

6 (13.6 %)

3.93

(0.71–21.53)

0.11

 More than two comorbidities

42 (33.0 %)

22 (26.5 %)

20 (45.4 %)

1.27

(0.45–3.54)

0.64

  1. CRE carbapenem-resistant infection, OR odds ratio, CI confidence interval, ATM antimicrobial